Salazar, Betsy H.
Hoffman, Kristopher A.
Lincoln, John A.
Karmonik, Christof
Rajab, Hamida
Helekar, Santosh A.
Khavari, Rose
Funding for this research was provided by:
National Institutes of Health (1R01DK134340-01, 1R01DK134340-01, 1R01DK134340-01, 1R01DK134340-01)
Article History
Received: 11 August 2023
Accepted: 6 November 2023
First Online: 25 January 2024
Declarations
:
: The study was approved by the Houston Methodist Research Institute’s Institutional Review Board (IRB) committee (PRO00035884) on March 3, 2022. Potential patient recruitment will start August 28, 2023. Written informed consent to participate in this study will be obtained from all participants. All experiments are performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki). Any substantive changes to study criteria, or other protocol modifications are communicated to IRB.
: Not applicable.
: The authors declare no competing interests.